EGFR and cancer: The ErbB, mTOR, TGF-beta and neurotrophin signaling pathways are identified as the cancer-specific pathways according to network fingerprint analysis, which have all believed to play crucial roles in controlling cell growth, proliferation, and survival, and therefore have close relations with cancer.